Acrospire Investment Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Acrospire Investment Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-12,633	Closed	-$66K	–	2749
2016 Q4	$66K	Sell	12,633 -5,022	-28%	-$23.6K	0.03%	1225
2016 Q3	$82K	Buy	17,655 +15,998	+965%	+$74.7K	0.05%	709
2016 Q2	$7K	Buy	+1,657	New	+$6.19K	0.01%	1830

Other funds holding DSCI

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Acrospire Investment Management's DSCI Position: Q1 2017 in Review

Acrospire Investment Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 12,633 shares — an estimated $66K sold.

Acrospire Investment Management first reported a position in DSCI in Q2 2016 and held it in 3 quarters. The position peaked at $82K in Q3 2016. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

Acrospire Investment Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
Acrospire Investment Management sold 12,633 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $66K.
Acrospire Investment Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2016 and held it in 3 quarters.
Acrospire Investment Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $82K in Q3 2016.
1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Acrospire Investment Management's 13F filing for Q1 2017, filed 4 May 2017.